The effect of cost on adherence to prescription medications in Canada

CMAJ. Canadian Medical Association Journal

Volumn 184, Issue 3, 2012, Pages 297-302

  Law, Michael R ^a   Cheng, Lucy ^a   Dhalla, Irfan A ^b,c,d   Heard, Deborah ^a   Morgan, Steven G ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c ST MICHAEL'S HOSPITAL   (Canada)

^d INSTITUTE FOR CLINICAL EVALUATIVE SCIENCES   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANADA; CHILD; CONTROLLED STUDY; DEMOGRAPHY; DRUG COST; HEALTH INSURANCE; HEALTH STATUS; HEALTH SURVEY; HOUSEHOLD; HUMAN; INCOME; MAJOR CLINICAL STUDY; PATIENT COMPLIANCE; PRESCRIPTION; PREVALENCE; SCHOOL CHILD; SEX DIFFERENCE; SOCIAL STATUS; SOCIOECONOMICS;

EID: 84857389424     PISSN: 08203946     EISSN: 14882329     Source Type: Journal    
DOI: 10.1503/cmaj.111270     Document Type: Article

References (22)

1. Morgan S, Raymond C, Mooney D, et al. The Canadian Rx atlas. Vancouver (BC): Centre for Health Services and Policy Research, University of British Columbia; 2008.
2. Canadian Institute for Health Information. Health care in Canada, 2008. Ottawa (ON): The Institute; 2008.
3. Osterberg L, Blaschke T. Adherence to medication. N Engl J Med 2005;353:487-97. (Pubitemid 41127293)
4. Lexchin J, Grootendorst P. Effects of prescription drug user fees on drug and health services use and on health status in vulnerable populations: a systematic review of the evidence. Int J Health Serv 2004;34:101-22. (Pubitemid 38393061)
5. Goldman DP, Joyce GF, Zheng Y. Prescription drug cost sharing: associations with medication and medical utilization and spending and health. JAMA 2007;298:61-9. (Pubitemid 47026771)
6. Kapur V, Basu K. Drug coverage in Canada: Who is at risk? Health Policy 2005;71:181-93. (Pubitemid 39647629)
7. CANSIM Table 109-5012. Ottawa (ON): Statistics Canada; 2009. Available: www5.statcan.gc.ca/cansim/pick-choisir ?lang =eng &searchTypeByValue= 1&id=1095012 (acces sed 2011 Mar. 5).
8. Canadian Institute for Health Information. Drug expenditure in Canada, 1985 to 2010. Ottawa (ON): The Institute; 2010.
9. Soumerai SB, Pierre-Jacques M, Zhang F, et al. Cost-related medication nonadherence among elderly and disabled medicare beneficiaries: a national survey 1 year before the Medicare drug benefit. Arch Intern Med 2006;166:1829-35. (Pubitemid 44455164)
10. Briesacher BA, Gurwitz JH, Soumerai SB. Patients at-risk for cost-related medication nonadherence: a review of the literature. J Gen Intern Med 2007;22:864-71. (Pubitemid 46763978)
11. Madden JM, Graves AJ, Zhang F, et al. Cost-related medication nonadherence and spending on basic needs following implementation of medicare, Part D. JAMA 2008;299:1922-8. (Pubitemid 351574922)
12. Kennedy J, Morgan S. A cross-national study of prescription nonadherence due to cost: data from the joint Canada-United States Survey of Health. Clin Ther 2006;28:1217-24. (Pubitemid 44376807)
13. Schoen C, Osborn R, Squires D, et al. How health insurance design affects access to care and costs, by income, in eleven countries. Health Aff (Millwood) 2010;29:2323-34.
14. Canadian Community Health Survey (CCHS) - Annual component. User guide. Ottawa (ON): Statistics Canada; 2009. Available: www.statcan.gc.ca/imdb-bmdi /document /3226 -D7 -T9 -V6 -eng.pdf (accessed 2011 July 27).
15. Andersen RM. Revisiting the behavioral model and access to medical care: Does it matter? J Health Soc Behav 1995;36:1-10.
16. Bootvar User Guide (Version 3.2 - SAS). Ottawa (ON): Statistics Canada; 2010.
17. Horton NJ, Lipsitz SR. Multiple imputation in practice. Am Stat 2001; 55:244-54.
18. Schoen C, Osborn R, Doty MM, et al. Toward higher -performance health systems: adults' health care experiences in seven countries, 2007. Health Aff (Millwood) 2007;26:w717-34.
19. Alexander C, Burleton D, Petramala D. Assessing the financial vulnerability of households across Canadian regions. Toronto (ON): TD Economics; 2011. Available: www .td .com /document /PDF /economics /special /td -economics -special -db0211 -householddebt.pdf (accessed 2011 Dec. 9)
20. Grootendorst P, Newman EC, Levine MAH. Validity of selfreported prescription drug insurance coverage. Health Rep 2003; 14: 35-46.
21. Stanbrook MB, Hébert PC, Coutts J, et al. Can Canada get on with national pharmacare already? CMAJ 2011;183:E1275.
22. Dhalla I, Smith M, Choudhry N, et al. Costs and benefits of free medications after myocardial infarction. Healthc Policy 2009;5 : 68-86.